Menu Search
Equities

M.D.B Corp

5594:TYO

M.D.B Corp

Actions
  • Price (JPY)500.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 30 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year M.D.B Corp's net income deteriorated -8.78% from 61.48m to 56.08m despite relatively flat revenues. A contributing factor has been the increase in the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales).
Gross margin16.02%
Net profit margin2.85%
Operating margin3.57%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in JPYView more

In 2024, M.D.B Corp increased its cash reserves by 14.71%, or 56.44m. Cash Flow from Financing totalled 53.31m or 2.71% of revenues. In addition the company generated 3.15m in cash from operations while cash used for investing totalled 10.00k.
Cash flow per share59.58
Price/Cash flow per share8.39
Book value per share366.48
Tangible book value per share366.29
More ▼

Balance sheet in JPYView more

M.D.B Corp has a Debt to Total Capital ratio of 27.41%.
Current ratio2.25
Quick ratio2.25
Total debt/total equity0.3777
Total debt/total capital0.2741
More ▼

Growth rates in JPY

Year on year, growth in earnings per share excluding extraordinary items dropped -8.78%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.